Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |

The Hottest Tech Sector Of 2020: Interview With Sayan Navaratnam

Uber transformed transportation when it spent a fortune turning ride-sharing into a mainstream mode of transportation. But the 2.0 version of ride-sharing is where the real disruption begins. It fixes everything that's wrong and latches onto a mega-trend the giants shouldn't h...
James Stafford, Oilprice.com | March 4, 2020 |

Buzz on the Bullboards: Who Stands to Benefit the Most from Easing COVID Restrictions?

(Image via TAAT Lifestyle & Wellness Ltd.) Investors don’t prosper on potential. Investors prosper on returns. And in recent years, there haven’t been many mining companies able to reward return-starved investors with a strong stock p...
Stockhouse Editorial | February 22, 2022 |

International students flocking to this company's education real estate model

(Click image to play video) While many businesses have struggled during the pandemic, there have been some that have prospered, and even increased their business. Vancouver-based, CIBT Education Group Inc. (MBA) ( TSX.MBA , OTCQX: MBAIF , Forum ) is one of t...
Isabella Zavarise | January 26, 2021 |

Building a Better Healthcare Solution Amid Great Demand

(Click image above to play video) Welcome to the one-stop shop for remote in-home health monitoring. Soon-to be publicly-listed Cloud DX Inc. ( TSX-V.ROSV.P , Forum ) is an innovative, cutting-edge company that offers ‘The Connected Health Kit&CloseCurlyQuot...
Dave Jackson | March 18, 2021 |

Enthusiast Gaming, flatex, wallstreet:online - scalable business without media interruption

Modern society lives on the Internet, or rather, everything that can be done and benefits online is done that way. Apart from the advantages that costly ways are saved, everything is done faster and decision-making processes are shortened. The more convenient and attractive th...
Mario Hose | March 4, 2020 |

Buzz on the Bullboards: Defying market expectations

Most market reviews are throwing around the dreaded R-word, “recession” like it’s going out of style. Once again, news headlines indicate that the markets may be steering towards one. It turns out that a combination of trade wars and ...
Jonathon Brown | August 11, 2022 |

good natured Products: transforming bio-based technology into earth-friendly products

Welcome to the Market Herald, I’m Simon Druker and you’re watching the Top Line. good natured Products Inc. is focused on transforming bio-based technology into earth-friendly products, available across the food sector. The Vancouver-ba...
Simon Druker | April 17, 2023 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Oil Deals Us an Instantly Profitable Rebound

Oil has indeed recovered from the key support, and our decision to open long positions became immediately profitable. It’s up to the bulls to prove their mettle right now – how far can they take the oil price? Let’s consult the charts and assess...
Przemyslaw Radomski, CFA | October 7, 2019 |
1 2 3 4 5 6 7 8 9 10 ...